Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated

European Journal of Human Genetics

Volumn 20, Issue 5, 2012, Pages 577-579

  Harinck, Femme ^a   Kluijt, Irma ^b   Van Mil, Saskia E ^c   Waisfisz, Quinten ^c   Van Os, Theo A M ^d   Aalfs, Cora M ^d   Wagner, Anja ^a   Olderode Berends, Maran ^e   Sijmons, Rolf H ^e   Kuipers, Ernst J ^a   Poley, Jan Werner ^a   Fockens, Paul ^d   Bruno, Marco J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

breast cancer susceptibility; familial pancreatic cancer; hereditary cancer; mutation analysis; pancreatic cancer susceptibility

Indexed keywords

PALB2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; PANCREAS CANCER; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; PREVALENCE; TUMOR SUPPRESSOR PROTEINS;

EID: 84859908346     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.226     Document Type: Article

References (14)

1. Rahman N, Seal S, Thompson D et al: PALB2, which encodes a BRCA2- interacting protein, is a breast cancer susceptibility gene. Nat Genet 2007; 39: 165-167. (Pubitemid 46184346)
2. Jones S, Hruban RH, Kamiyama M et al: Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009; 324: 217.
3. Erkko H, Xia B, Nikkila J et al: A recurrent mutation in PALB2 in Finnish cancer families. Nature 2007; 446: 316-319. (Pubitemid 46426155)
4. Tischkowitz MD, Sabbaghian N, Hamel N et al: Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. Gastroenterology 2009; 137: 1183-1186.
5. Casadei S, Norquist BM, Walsh T et al: Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res 2011; 71: 2222-2229.
6. Hellebrand H, Sutter C, Honisch E et al: Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer. Hum Mutat 2011; 32: E2176-E2188.
7. Hofstatter EW, Domchek SM, Miron A et al: PALB2 mutations in familial breast and pancreatic cancer. Fam Cancer 2011; 10: 225-231.
8. Peterlongo P, Catucci I, Pasquini G et al: PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer. Breast Cancer Res Treat 2011; 126: 825-828.
9. Stadler ZK, Salo-Mullen E, Sabbaghian N et al: Germline PALB2 mutation analysis in breast-pancreas cancer families. J Med Genet 2011; 48: 523-525.
10. Slater EP, Langer P, Niemczyk E et al: PALB2 mutations in European familial pancreatic cancer families. Clin Genet 2010; 78: 490-494.
11. Brand RE, Lerch MM, Rubinstein WS et al: Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007; 56: 1460-1469. (Pubitemid 47517845)
12. Xia B, Dorsman JC, Ameziane N et al: Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 2007; 39: 159-161. (Pubitemid 46184344)
13. Ameziane N, van den Ouweland AM, Adank MA et al: Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer. Breast Cancer Res Treat 2009; 118: 651-653.
14. Adank MA, van Mil SE, Gille JJ, Waisfisz Q, Meijers-Heijboer H: PALB2 analysis in BRCA2-like families. Breast Cancer Res Treat 2011; 127: 357-362.